Huh Hoyoung
SEC insider (Form 3/4/5 filer). CIK 0001401267. Director & 10% Owner at Akari Therapeutics Plc (AKTX) and 2 other issuers. 15 reported Form 4/5 transactions since Sep 2024; latest on Oct 5, 2026. Located in TAMPA, FL.
Companies Huh Hoyoung has filed insider reports for
- Akari Therapeutics Plc (AKTX): Director, 10% Owner
- PLIANT THERAPEUTICS, INC. (PLRX): Director
- Peak Bio, Inc. (PKBO): Director, 10% Owner
Huh Hoyoung
CIK: 0001401267
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Oct 5, 2026AKTX
Akari Therapeutics Plc
AwardDirect6.2K shares at avg. $7.90$49K - Aug 18, 2026AKTX
Akari Therapeutics Plc
AwardDirect17.2K shares at avg. $7.90$136K - Jun 11, 2026PLRX
PLIANT THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
70K shares- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectWarrants to purchase American Depositary Shares ("ADRs")
618.7K shares- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectPre-Funded Warrants to purchase ADRs
618.7K shares at avg. $0.40- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectWarrants to purchase ADRs
3.1M shares- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectPre-Funded Warrants to purchase ADRs
3.1M shares at avg. $0.40- - Jun 5, 2025PLRX
PLIANT THERAPEUTICS, INC.
AwardDirectCommon Stock (Right to Buy)
30K shares- - Mar 20, 2025AKTX
Akari Therapeutics Plc
AwardDirectStock Option (Right to Buy)
175K shares- - Mar 20, 2025AKTX
Akari Therapeutics Plc
AwardDirectStock Option (Right to Buy)
225K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 5, 2026 |  AKTX Akari Therapeutics Plc | Award | 6,160 | $7.90 | $48,658 | Direct |
| Aug 18, 2026 | AKTX Akari Therapeutics Plc | Award | 17,249 | $7.90 | $136,250 | Direct |
| Jun 11, 2026 |  PLRX PLIANT THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 70,000 | - | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Warrants to purchase American Depositary Shares ("ADRs") | 618,658 | - | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Pre-Funded Warrants to purchase ADRs | 618,658 | $0.40 | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Warrants to purchase ADRs | 3,093,293 | - | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Pre-Funded Warrants to purchase ADRs | 3,093,293 | $0.40 | - | Direct |
| Jun 5, 2025 | PLRX PLIANT THERAPEUTICS, INC. | Award Common Stock (Right to Buy) | 30,000 | - | - | Direct |
| Mar 20, 2025 | AKTX Akari Therapeutics Plc | Award Stock Option (Right to Buy) | 175,000 | - | - | Direct |
| Mar 20, 2025 | AKTX Akari Therapeutics Plc | Award Stock Option (Right to Buy) | 225,000 | - | - | Direct |
1-10 of 15 transactions